A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Benzethidine
Cefazedone
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefazedone.
Benzethidine
Cefpirome
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefpirome.
Benzethidine
Cefozopran
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefozopran.
Benzethidine
Cefbuperazone
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefbuperazone.
Benzethidine
Cefetamet
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefetamet.
Benzethidine
Cefsulodin
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefsulodin.
Benzethidine
Cefodizime
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefodizime.
Benzethidine
Cefcapene
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefcapene.
Benzethidine
Cefatrizine
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefatrizine.
Benzethidine
Flomoxef
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Flomoxef.
Benzethidine
Cefroxadine
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefroxadine.
Benzethidine
Cefminox
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefminox.
Benzethidine
Ceftolozane
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftolozane.
Benzethidine
Ceftaroline fosamil
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftaroline fosamil.
Benzethidine
Ceftobiprole
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftobiprole.
Benzethidine
Latamoxef
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Latamoxef.
Benzethidine
Cepeginterferon alfa-2B
The risk or severity of bleeding can be increased when Nafamostat is combined with Cepeginterferon alfa-2B.
Benzethidine
Peginterferon beta-1a
The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon beta-1a.
Benzethidine
Dinutuximab
The risk or severity of bleeding can be increased when Nafamostat is combined with Dinutuximab.
Benzethidine
Blinatumomab
The risk or severity of bleeding can be increased when Nafamostat is combined with Blinatumomab.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3